Paper3905967
YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.
Piontek GE and 6 others. J Immunol, 1985. Cited by 167 papers, by iCite.
Cite this record
ConductScience Library. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage. Papers, record 3905967. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3905967
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Variation | Major topic |
| H-2 Antigens | Major topic |
| Interferon Type I | Major topic |
| Killer Cells, Natural | Major topic |
| Animals | |
| Antilymphocyte Serum | |
| Cell Line | |
| Cytotoxicity, Immunologic | |
| Mice | |
| Neoplasm Transplantation | |
| T-Lymphocytes, Cytotoxic | |
| beta 2-Microglobulin |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 2 R01 CA 25250-07 | NCI NIH HHS | United States | R01CA252500 | PubMed | NIH RePORTER |
| 5 R01 CA 26782-05 | NCI NIH HHS | United States | R01CA267820 | PubMed | NIH RePORTER |
| R01CA025250 | NIH | NIH RePORTER | |||
| R01CA026782 | NIH | NIH RePORTER |
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 167 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39511139 | Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39511139 | PubMed |
| 39201555 | A New Look at Immunogenetics of Pregnancy: Maternal Major Histocompatibility Complex Class I Educates Uterine Natural Killer Cells. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39201555 | PubMed |
| 32903482 | Use of Cell and Genome Modification Technologies to Generate Improved "Off-the-Shelf" CAR T and CAR NK Cells. | Front Immunol | 2020 | https://conductscience.org/library/papers/32903482 | PubMed |
| 32879472 | Human immunology and immunotherapy: main achievements and challenges. | Cell Mol Immunol | 2021 | https://conductscience.org/library/papers/32879472 | PubMed |
| 29466757 | Quiescent Tissue Stem Cells Evade Immune Surveillance. | Immunity | 2018 | https://conductscience.org/library/papers/29466757 | PubMed |
| 26911188 | Antitumour actions of interferons: implications for cancer therapy. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/26911188 | PubMed |
| 26487683 | Agonist antibody that induces human malignant cells to kill one another. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26487683 | PubMed |
| 24795726 | Activating killer cell Ig-like receptors in health and disease. | Front Immunol | 2014 | https://conductscience.org/library/papers/24795726 | PubMed |
| 22661698 | Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice. | Blood | 2012 | https://conductscience.org/library/papers/22661698 | PubMed |
| 22516959 | TLR9 and MyD88 are crucial for the development of protective immunity to malaria. | J Immunol | 2012 | https://conductscience.org/library/papers/22516959 | PubMed |
| 21475006 | StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial. | Ann Surg | 2011 | https://conductscience.org/library/papers/21475006 | PubMed |
| 19949065 | The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growth. | J Immunol | 2010 | https://conductscience.org/library/papers/19949065 | PubMed |
| 15378281 | NK cell activation and tumor infiltration are involved in the antitumor mechanism of Virulizin. | Cancer Immunol Immunother | 2005 | https://conductscience.org/library/papers/15378281 | PubMed |
| 14568980 | Elimination in vivo of developing T cells by natural killer cells. | J Exp Med | 2003 | https://conductscience.org/library/papers/14568980 | PubMed |
| 11819514 | On the cell biology of pit cells, the liver-specific NK cells. | World J Gastroenterol | 2000 | https://conductscience.org/library/papers/11819514 | PubMed |
| 11089888 | Biological properties associated with the enhanced lung-colonizing potential in a B16 murine melanoma line grown in a medium conditioned by syngeneic Corynebacterium parvum-elicited macrophages. | Clin Exp Metastasis | 1999 | https://conductscience.org/library/papers/11089888 | PubMed |
| 11050046 | Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. | Hepatology | 2000 | https://conductscience.org/library/papers/11050046 | PubMed |
| 9858511 | Genetic control of natural killing and in vivo tumor elimination by the Chok locus. | J Exp Med | 1998 | https://conductscience.org/library/papers/9858511 | PubMed |
| 9482903 | Induction of transporter associated with antigen processing by interferon gamma confers endothelial cell cytoprotection against natural killer-mediated lysis. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9482903 | PubMed |
| 8930665 | Flavivirus-induced up-regulation of MHC class I antigens; implications for the induction of CD8+ T-cell-mediated autoimmunity. | Immunol Rev | 1996 | https://conductscience.org/library/papers/8930665 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| B2M | 567 | PubTator's text mining | https://conductscience.org/library/genes/567 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3905967
GET https://conductscience.org/api/papers/v1/3905967/cited_by?page=2